{"version":"1.0","provider_name":"BIOENGINEER.ORG","provider_url":"https:\/\/bioengineer.org","author_name":"BIOENGINEER.ORG","author_url":"https:\/\/bioengineer.org","title":"Melanoma: dabrafenib and trametinib have added benefit","type":"rich","width":600,"height":338,"html":"
Melanoma: dabrafenib and trametinib have added benefit<\/a><\/blockquote>